B cells have important antibody-independent effector functions including cytokine production that parallels T cells in magnitude and regulation. It has also been established that B cell-mediated antibody-independent effector functions are central to the pathogenesis of autoimmune diseases. These observations highlight the need to understand the precise phenotype and function of human effector B cells and their disregulation in autoimmunity. However, both in mice and humans, effector B cells are ill-defined and poorly understood. Over the last 3 years, we have identified a previously unrecognized population of human B cells that while displaying isotype switch and bearing a significant degree of somatic hypermutation, are distinct from conventional memory cells in the lack of CD27 expression;lower degree of mutation;expression of activation markers;expression of markers of trafficking to systemic inflamed tissues;and dependence on BAFF for survival. All the evidence combined, we postulate that these cells represent effector B cells that are greatly expanded systemically in SLE and in the synovial fluid of patients with Rheumatoid Arthritis and contribute to the pathogenesis of these diseases in antibody-independent fashion. The overall goal of this project is to understand the ontology, homeostasis, selection and function of effector B cells in human autoimmune disease with particular emphasis in SLE. This goal will be accomplished through the following specific aims: 1) To define the ontology of effector B cells (Beff) in SLE;2) To understand the homeostasis of effector B cells in SLE;3) To understand the selection of autoreactivity within the Beff effector compartment;and 4) To understand division of labor in human effector B cells. The information obtained should substantially improve our ability to therapeutically target populations of interest either for enhancement (vaccine responses) or dampening (autoimmune responses and transplantation). Finally, the knowledge gained will also greatly facilitate investigators ability to understand the immunological mechanisms behind the benefit (or lack thereof) of clinical interventions such as vaccination or B cell targeting therapies. This project has great synergy with the studies of other unique regulatory and effector B cell populations studied in projects 1 (human transitional cells) and projects 3-4 (mouse effector and Bin cells).

Public Health Relevance

B cell cells are critical players in orchestrating protective immune responses against infections. At the same time, they play important pathogenic roles that contribute to disease in multiple autoimmune conditions including SLE. It is unknown at this time whether the different functions are played by different B cell populations or by the same cells after they acquire different function in the disease environment. We have discovered novel human B cell subsets and have started to characterize their function regarding antibody and cytokine production. These cells, effector B cells, will be extensively characterized in this project in terms of homeostasis and function. The expected results will greatly help our ability to understand, diagnose and treat SLE and other human autoimmune diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI078907-05
Application #
8707315
Study Section
Special Emphasis Panel (ZAI1-PA-I)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
5
Fiscal Year
2014
Total Cost
$311,834
Indirect Cost
$37,982
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Meednu, Nida; Zhang, Hengwei; Owen, Teresa et al. (2016) Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis. Arthritis Rheumatol 68:805-16
Rahimi, Homaira; Bell, Richard; Bouta, Echoe M et al. (2016) Lymphatic imaging to assess rheumatoid flare: mechanistic insights and biomarker potential. Arthritis Res Ther 18:194
Kuzin, Igor I; Kates, Stephen L; Ju, Yawen et al. (2016) Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodes. Eur J Immunol 46:1752-7
Newell, K A; Asare, A; Sanz, I et al. (2015) Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am J Transplant 15:2908-20
Adlowitz, Diana G; Barnard, Jennifer; Biear, Jamie N et al. (2015) Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response. PLoS One 10:e0128269
Bird, Anna K; Meednu, Nida; Anolik, Jennifer H (2015) New insights into B cell biology in systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol 27:461-7
Wilmore, Joel R; Asito, Amolo S; Wei, Chungwen et al. (2015) AID expression in peripheral blood of children living in a malaria holoendemic region is associated with changes in B cell subsets and Epstein-Barr virus. Int J Cancer 136:1371-80
Halliley, Jessica L; Tipton, Christopher M; Liesveld, Jane et al. (2015) Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow. Immunity 43:132-45
Bouta, Echoe M; Li, Jie; Ju, Yawen et al. (2015) The role of the lymphatic system in inflammatory-erosive arthritis. Semin Cell Dev Biol 38:90-7
Wei, Chungwen; Jenks, Scott; Sanz, Iñaki (2015) Polychromatic flow cytometry in evaluating rheumatic disease patients. Arthritis Res Ther 17:46

Showing the most recent 10 out of 53 publications